• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫温泉吸入对长新冠综合征的影响:以水疗为中心、双盲、随机对照的初步研究。

Effects of sulphur thermal water inhalations in long-COVID syndrome: Spa-centred, double-blinded, randomised case-control pilot study.

机构信息

School of Thermal Medicine, Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

出版信息

Clin Med (Lond). 2024 Nov;24(6):100251. doi: 10.1016/j.clinme.2024.100251. Epub 2024 Oct 5.

DOI:10.1016/j.clinme.2024.100251
PMID:39370044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11570715/
Abstract

BACKGROUND

The long-COVID syndrome is characterised by a plethora of symptoms. Given its social and economic impact, many studies have stressed the urgency of proposing innovative strategies other than hospital settings. In this double-blinded, randomised, case-control trial, we investigate the effects of sulphur thermal water inhalations, rich in HS, compared to distilled water inhalations on symptoms, inflammatory markers and nasal microbiome in long-COVID patients.

METHODS

About 30 outpatients aged 18-75 with positive diagnosis for long-COVID were randomised in two groups undergoing 12 consecutive days of inhalations. The active group (STW) received sulphur thermal water inhalations whereas the placebo group received inhalations of sterile distilled non-pyrogenic water (SDW). Each participant was tested prior treatment at day 1 (T0), after the inhalations at day 14 (T1) and at 3 months follow-up (T2). At each time point, blood tests, nasal swabs for microbiome sampling, pulmonary functionality tests (PFTs) and pro-inflammatory marker measure were performed.

RESULTS

The scores obtained in the administered tests (6MWT, Borg score and SGRQ) at T0 showed a significant variation in the STW group, at T1 and T2. Serum cytokine levels and other inflammatory biomarkers reported a statistically significant decrease. Some specific parameters of PFTs showed ameliorations in the STW group only. Changes in the STW nasopharyngeal microbiota composition were noticed, especially from T0 to T2.

CONCLUSIONS

Inhalations of sulphur thermal water exerted objective and subjective improvements on participants affected by long-COVID. Significant reduction of inflammatory markers, dyspnoea scores and quantitative and qualitative changes in the nasopharyngeal microbiome were also assessed.

摘要

背景

长新冠综合征的特征是多种症状。鉴于其对社会和经济的影响,许多研究强调除了医院环境外,迫切需要提出其他创新策略。在这项双盲、随机、病例对照试验中,我们研究了富含 HS 的硫磺温泉吸入与蒸馏水吸入对长新冠患者症状、炎症标志物和鼻腔微生物组的影响。

方法

约 30 名年龄在 18-75 岁之间、长新冠诊断阳性的门诊患者被随机分为两组,连续接受 12 天的吸入治疗。实验组(STW)接受硫磺温泉吸入,对照组(SDW)接受无菌、非致热蒸馏水吸入。每位参与者在治疗前第 1 天(T0)、吸入后第 14 天(T1)和 3 个月随访(T2)进行测试。在每个时间点,进行血液检查、鼻腔拭子微生物组采样、肺功能测试(PFTs)和促炎标志物测量。

结果

T0 时进行的测试(6MWT、Borg 评分和 SGRQ)中,实验组的评分在 T1 和 T2 时出现显著变化。血清细胞因子水平和其他炎症生物标志物报告有统计学意义的下降。PFTs 的一些特定参数仅在实验组中显示出改善。STW 鼻咽微生物组组成的变化在 T0 到 T2 期间也被注意到。

结论

硫磺温泉吸入对长新冠患者产生了客观和主观的改善。炎症标志物、呼吸困难评分以及鼻咽微生物组的定量和定性变化也显著减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/073b15710182/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/696cf4eb451e/sc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/463388160538/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/1dcc97c31d30/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/a46842da19c5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/d45383622a4f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/073b15710182/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/696cf4eb451e/sc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/463388160538/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/1dcc97c31d30/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/a46842da19c5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/d45383622a4f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ad/11570715/073b15710182/gr5.jpg

相似文献

1
Effects of sulphur thermal water inhalations in long-COVID syndrome: Spa-centred, double-blinded, randomised case-control pilot study.硫温泉吸入对长新冠综合征的影响:以水疗为中心、双盲、随机对照的初步研究。
Clin Med (Lond). 2024 Nov;24(6):100251. doi: 10.1016/j.clinme.2024.100251. Epub 2024 Oct 5.
2
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验(SAINT)评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力:一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
Sulfurous-arsenical-ferruginous thermal water nasal inhalation and irrigation in children with recurrent upper respiratory tract infections: Clinical outcomes and predictive factors.硫磺-砷-铁温泉水鼻腔吸入和冲洗治疗复发性上呼吸道感染儿童:临床结果及预测因素
Am J Otolaryngol. 2021 Nov-Dec;42(6):103083. doi: 10.1016/j.amjoto.2021.103083. Epub 2021 May 21.
7
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.双盲、随机、对照临床试验评估同种异体间充质基质细胞治疗 COVID-19 所致急性呼吸窘迫综合征患者的疗效(COVID-AT):一项随机对照试验的研究方案的结构总结。
Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1.
8
A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.一项关于漱口剂在降低住院 COVID-19 患者口腔病毒载量中的四重盲、随机对照试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 14;21(1):785. doi: 10.1186/s13063-020-04634-2.
9
Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.羟氯喹治疗初级保健环境中成人 COVID-19 感染患者(LIBERTY):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):44. doi: 10.1186/s13063-020-04989-6.
10
Sulphurous-arsenical-ferruginous (thermal) water inhalations reduce nasal respiratory resistance and improve mucociliary clearance in patients with chronic sinonasal disease: preliminary outcomes.含硫-砷-铁(热)水吸入可降低慢性鼻-鼻窦炎患者的鼻呼吸阻力并改善黏液纤毛清除功能:初步结果
Acta Otolaryngol. 2007 Jun;127(6):613-7. doi: 10.1080/00016480600951525.

引用本文的文献

1
Emerging Evidence on Balneotherapy and Thermal Interventions in Post-COVID-19 Syndrome: A Systematic Review.关于新冠后综合征中浴疗法和热干预的新证据:一项系统综述
Healthcare (Basel). 2025 Jan 7;13(2):96. doi: 10.3390/healthcare13020096.

本文引用的文献

1
Human nasal microbiota shifts in healthy and chronic respiratory disease conditions.人类鼻腔微生物群在健康和慢性呼吸道疾病状态下会发生变化。
BMC Microbiol. 2024 Apr 27;24(1):150. doi: 10.1186/s12866-024-03294-5.
2
Cardiovascular disease as part of Long COVID: a systematic review.作为长期新冠一部分的心血管疾病:一项系统综述
Eur J Prev Cardiol. 2025 Apr 22;32(6):485-498. doi: 10.1093/eurjpc/zwae070.
3
The Microbiota in Long COVID.新冠长期症状中的微生物群
Int J Mol Sci. 2024 Jan 22;25(2):1330. doi: 10.3390/ijms25021330.
4
How methodological pitfalls have created widespread misunderstanding about long COVID.方法学上的缺陷是如何导致对长期新冠的广泛误解的。
BMJ Evid Based Med. 2024 May 22;29(3):142-146. doi: 10.1136/bmjebm-2023-112338.
5
Corrigendum to "The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis".《住院和非住院人群中长新冠的患病率及长期健康影响:一项系统评价和荟萃分析》的勘误
EClinicalMedicine. 2023 May;59:101959. doi: 10.1016/j.eclinm.2023.101959. Epub 2023 Apr 19.
6
Author Correction: Long COVID: major findings, mechanisms and recommendations.作者更正:新冠长期症状:主要发现、机制及建议。
Nat Rev Microbiol. 2023 Jun;21(6):408. doi: 10.1038/s41579-023-00896-0.
7
A review of cytokine-based pathophysiology of Long COVID symptoms.基于细胞因子的长新冠症状病理生理学综述。
Front Med (Lausanne). 2023 Mar 31;10:1011936. doi: 10.3389/fmed.2023.1011936. eCollection 2023.
8
Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors.维生素 D 水平低与 COVID-19 幸存者的长新冠综合征有关。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):e1106-e1116. doi: 10.1210/clinem/dgad207.
9
In Vitro Antiviral and Anti-Inflammatory Activities of -Acetylglucosamine: Development of an Alternative and Safe Approach to Fight Viral Respiratory Infections.体外抗 病毒和抗炎活性的 N-乙酰葡萄糖胺:开发一种对抗病毒呼吸道感染的替代和安全方法。
Int J Mol Sci. 2023 Mar 7;24(6):5129. doi: 10.3390/ijms24065129.
10
Twelve-month clinical, functional, and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia.因感染新型冠状病毒肺炎住院患者的12个月临床、功能和影像学结果。
J Med Virol. 2023 Feb;95(2):e28524. doi: 10.1002/jmv.28524.